iHeart

About:

iHeart is a biotechnology company that develops regenerative medicinal products for severe heart failure, using iPSC technologies.

Website: http://iheartjapan.jp/

Top Investors: SBI Investment, Mitsubishi UFJ Capital, UntroD Capital, Miyako Capital

Description:

iHeart Japan Corporation is developing regenerative medicinal products for severe heart failure, using iPSC technologies. Its base technologies were invented by scientists of Kyoto University.

Total Funding Amount:

900M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kyoto-shi, Kyoto, Japan

Founded Date:

2013-04-18

Contact Email:

info(AT)iheartjapan.jp

Founders:

Kenji Kakuta

Number of Employees:

11-50

Last Funding Date:

2016-05-16

IPO Status:

Private

Industries: